Highlights Lavipharm S.A.

Equities

LAVI

GRS246003008

Market Closed - Athens S.E. Other stock markets 15:19:06 28/05/2024 BST			5-day change	1st Jan Change
0.942 ^EUR	-0.84%		-3.88%	+18.34%

02-28	Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	02-28	CI
Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi.	12-10	CI
Lavipharm S.A. signing of an asset purchase agreement to acquire Lonarid N and Lonalgal from Boehringer Ingelheim International GmbH.	11-30	CI
Lavipharm S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-08	CI
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	21/09/23	CI
Lavipharm S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23	CI
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	15/09/22	CI
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	21/03/22	CI
Lavipharm S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	29/09/21	CI
Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	26/04/21	CI
Zentiva Reinforces Its Presence in Greece by Signing A Partnership with the Company Lavipharm S.A	19/10/20	CI
Lavipharm Announces Consolidated Earnings Results for the First Half of 2015	21/09/15	CI
Robertet SA and Codif Recherche & Nature acquired Hitex S.A. from Lavipharm S.A. for €3.1 million.	01/01/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Like the pros, access all the transcripts and spot the best opportunities before anyone else.

Unlock them now!

fermer